FDA
approval
· 2021-02-11
FDA Approved: TREPROSTINIL — Original Application (Alembic Pharmaceuticals Inc.)
Summary
The FDA approved Alembic Pharmaceuticals' original ANDA for treprostinil, enabling the generic version of the drug to be marketed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TREPROSTINIL (TREPROSTINIL)